F-Prime Capital β 2016 Investments
3 investments dated 2016 Β· listed companies and verified rows first Β· show all
Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.
AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US
Sajith Wickramasekara(Founder/CEO)inAshutosh Singhal(Director)Ashu Singhal(Founder)in
BoardMiles Grimshaw(Director)in
Co-investorsAlkeon InnovationAndreessen HorowitzArtisanal VenturesBalaji SrinivasanDraper AssociatesICONIQ+12 more
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases.
BiotechDigital HealthHealthtechCambridge, US
PETER M. HECHT(Executive Officer, Director)MARK G. CURRIE(Executive Officer)HALLEY E. GIBLERT(Executive Officer)THOMAS GRANEY(Executive Officer)THOMAS A. MCCOURT(Executive Officer)
BoardTERRANCE G. MCGUIRE(Director)
Co-investorsMountain Group CapitalRidgeback CapitalVenrockMaverick VenturesPolaris Partners
Day One (part of Servier) is a biopharmaceutical company developing targeted oncology medicines, with a focus on cancers affecting patients of all ages, including pediatric low-grade glioma (pLGG).
BiotechHealthtechCambridge, US
MICHAEL J. KAUFMAN(Executive Officer)DONALD BERGSTROM(Executive Officer)ANNA PROTOPAPAS(Executive Officer, Director)TIMOTHY LOWINGER(Executive Officer)EVA JACK(Executive Officer)WAYNE FOSTER(Executive Officer)
Co-investorsBain Capital Life SciencesLightstone VenturesNew Enterprise Associates (NEA)Nextech InvestPfizer Venture InvestmentsRho Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.